查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922936

一次性塑胶血袋市场按材料类型、包装类型、灭菌方法、容量、应用、最终用户和销售管道划分—全球预测（2026-2032 年）

Disposable Plastic Blood Bag Market by Material Type, Packaging Type, Sterilization Method, Capacity, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，一次性塑胶血袋市场价值将达到 30.1 亿美元，到 2026 年将成长至 32.5 亿美元，到 2032 年将达到 53.4 亿美元，复合年增长率为 8.53%。

主要市场统计数据
基准年 2025 30.1亿美元
预计年份：2026年 32.5亿美元
预测年份：2032年 53.4亿美元
复合年增长率 (%) 8.53%

一次性塑胶血袋是现代输血医学和临床供应链的基础，支持所有医疗机构的血液采集、处理和储存。这些产品融合了材料科学、灭菌通讯协定和法规遵循性，提供一次性解决方案，保护捐血者和收件人。近年来，随着医疗机构效率的提高、交叉感染风险的降低以及库存管理的简化，血袋的作用日益扩大。因此，供应商和医疗机构必须在临床性能要求、生产实际操作和环境因素之间取得平衡。

创新路径涵盖了从传统PVC共混物到新兴非PVC替代品的各种材料技术，以及从单袋包装到旨在实现组件分离的多袋包装的各种包装形式。灭菌方法（伽玛射线、环氧乙烷、电子束、高压釜）会影响产品的完整性和供应链的时效性。此外，医院、诊所、诊断实验室和研究机构等终端使用者各自有着独特的规格要求、采购週期和品质保证系统。这就要求製造商开发适应性强的平台和可扩展的製程流程，以因应不断变化的临床通讯协定和监管要求。

该领域近期重点工作包括提高生物相容性、确保输血链全程可追溯性，以及在不影响无菌性和病人安全的前提下推动循环经济。製造商、采购团队和临床治理机构之间的策略合作至关重要，以确保产品发展与医疗服务目标和永续性保持一致。

材料、灭菌技术和采购模式的变革性变化正在重新定义产品生命週期和临床工作流程。

一次性塑胶血袋领域正经历一系列相互交织的变革，其意义远不止于简单的产品改进。环境、监管和安全方面的考量正在加速材料创新，製造商正在评估非PVC替代品。这些新材料必须在柔软性、透明度、化学相容性和低温运输耐久性方面达到或超过PVC的性能，同时也要与现有生产线相容。同时，灭菌技术的加工效率、残留物分布以及与新型聚合物的兼容性也正在重新评估，这促使人们重新审视供应链的进度安排和设施认证。

2025年美国关税调整对采购、生产地点选择及采购韧性的累积影响

2025年实施的关税政策对一次性塑胶血袋供应链产生了连锁反应，改变了采购的优先事项和计算方式。关税调整影响了进口原料和成品组件的相对成本竞争力，促使製造商和采购机构重新评估其供应商基础和库存管理方式。因此，拥有多元化采购基础和国内生产能力的公司更具韧性，而依赖单一国家供应商的公司则面临更大的物流和合规方面的挑战。

关键细分洞察揭示了应用需求、材料选择、消毒方法和包装形式如何共同决定临床适用性。

对应用领域的深入分析揭示了不同的性能和设计要求。根据应用，市场可细分为血浆、血小板、红血球和全血。在血浆中，冷沉淀、新鲜冷沉淀和血浆衍生物的要求各不相同，这会影响血袋是否适用于冷冻和分馏过程。对于血小板，单采血小板和随机供体血小板分别需要特定的处理方法，这会影响抗凝血剂的用量、气体渗透性和储存方式。对于红血球采集，诸如去除白血球、标准和洗涤等选项至关重要，而过滤器和连接设计会影响处理流程。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势正在影响监管合规、分销和采用模式。

区域趋势对产品适应症、监管合规性和分销模式有显着影响。在美洲市场，机构采购流程、严格的血液监测要求以及对品质保证的高度重视推动了市场的成熟，这要求供应商维护完善的文件管理和快速回应的技术支援。该地区的监管管道倾向于支持以临床证据为支撑的渐进式创新，而供应网络则优先考虑医院系统和大型血站的可靠性和应对力。

主要企业洞察，揭示了构成一次性血袋供应竞争优势的能力、策略性投资和检验优势。

为了维持业务永续营运，一次性血袋领域的主要企业正加大对模组化产品平台、灭菌相容性测试和供应商多元化的投资。许多领先製造商强调品管系统、合规记录和全面的检验文件，以支援大型医院和血站采用其产品。透过提供技术培训、客製化标籤和与医院资讯系统连接的扩展可追溯性系统等服务，企业正日益实现差异化竞争优势。

为製造商和采购商提供切实可行的建议，以加速材料创新、保障供应链安全并提高永续性，同时又不影响临床效能。

产业领导者应优先考虑平衡策略，同时推动材料创新、监管合规和供应链韧性。投资开发检验的非PVC原型，并针对各种灭菌方法实施严格的兼容性测试，可以降低材料相关的监管和环境压力。同时，企业应制定正式的供应商多元化计划，并考虑建立区域生产中心，以减轻关税造成的成本波动和物流中断。这种双管齐下的方法既能提高营运柔软性，又能维持临床效能。

调查方法概述了为确保研究结果的可靠性和实用性而采用的多学科资料收集、检验和交叉检验程序。

本分析综合了来自临床相关人员、生产专家和采购人员的定性一手信息，并辅以材料科学、灭菌技术和法规指南方面的二手文献。一手资讯透过结构化访谈和技术咨询收集，重点在于产品规格、灭菌相容性以及最终用户的操作限制。二级资讯来源包括同行评审出版物、法规指南文件以及探讨聚合物性能和血液监测最佳实践的行业技术论文。

结论：对不断变化的一次性血袋市场中相关人员的关键策略要务、新兴风险和机会领域进行综合分析

结论总结了相关人员在应对一次性塑胶血袋市场时需要考虑的策略要务、新兴风险和优先行动。

一次性塑胶血袋产业正处于转折点，材料创新、灭菌验证、不断演变的采购方式以及地缘政治因素共同交织，重塑竞争格局。相关人员必须在确保临床性能和安全性的同时，应对改善环境绩效和控制检验带来的成本风险。投资于经验证的非PVC替代品、实现生产和采购管道多元化并加强与临床终端用户合作的企业，将更有能力应对监管变化和供应链波动。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 销售管道分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 一次性塑胶血袋市场（依材料类型划分）

  • 不含聚氯乙烯
  • PVC

9. 一次性塑胶血袋市场（依包装类型划分）

  • 双层袋
  • 卫星套件
  • 米包

第十章 依灭菌方法分類的一次性塑胶血袋市场

  • 高压釜
  • 电子束
  • 环氧乙烷
  • 伽玛射线

第十一章 一次性塑胶血袋市场（以销售量计）

  • 250～500ml
  • 500毫升或以上
  • 250毫升或以下

第十二章：一次性塑胶血袋市场（按应用领域划分）

  • 电浆
    • 冷沉淀物
    • 新鲜冷沉淀物
    • 血浆製品
  • 血小板
    • 血小板分离术
    • 随机供体血小板
  • 红血球
    • 白血球去除
    • 标准
    • 洗过的血
  • 全血

第十三章 一次性塑胶血袋市场（依最终用户划分）

  • 诊所
  • 诊断实验室
  • 医院
  • 研究所

第十四章 一次性塑胶血袋市场（依销售管道划分）

  • 直销
  • 批发商

第十五章 各地区一次性塑胶血袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 一次性塑胶血袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国一次性塑胶血袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国一次性塑胶血袋市场

第十七章：中国一次性塑胶血袋市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma, Inc.
  • B. Braun Melsungen SE
  • Baxter International Inc.
  • Beijing Bode Sangte Blood Equipment Technology Development Center
  • Fresenius Kabi AG
  • GenesisBPS
  • Grifols, SA
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • Innvol Medical India Ltd.
  • JMS Co., Ltd.
  • Macopharma SA
  • Ningbo David Medical Device Co., Ltd.
  • Nipro Corporation
  • Poly Medicure Limited
  • SB-Kawasumi Laboratories Inc.
  • Shandong Yimei Medical Technology Co., Ltd.
  • Shanghai Transfusion Technology Co., Ltd.
  • Sichuan Mianzhu Hongji Pharmaceutical Co., Ltd.
  • SURU International Pvt. Ltd.
  • Terumo Corporation
  • Wego Holding Co., Ltd.
  • Zhengzhou Feilong Medical Equipment Co., Ltd.
Product Code: MRR-867BED9A9E6A

The Disposable Plastic Blood Bag Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.25 billion in 2026, with a CAGR of 8.53%, reaching USD 5.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.25 billion
Forecast Year [2032] USD 5.34 billion
CAGR (%) 8.53%

Disposable plastic blood bags remain a cornerstone of modern transfusion medicine and clinical supply chains, underpinning blood collection, processing, and storage across care settings. These products combine material science, sterilization protocols, and regulatory compliance to deliver single-use solutions that protect both donors and recipients. Recently, their role has broadened as facilities pursue efficiency gains, lower cross-contamination risk, and more streamlined inventory practices. Consequently, suppliers and healthcare providers must reconcile clinical performance requirements with manufacturing practicability and environmental stewardship.

The innovation trajectory spans materials such as traditional PVC blends and emerging non-PVC alternatives, alongside packaging configurations ranging from single to multi-bag systems tailored for component separation. Sterilization choices-gamma, ethylene oxide, electron beam, and autoclave-impact both product integrity and supply chain timing. Moreover, end users including hospitals, clinics, diagnostic laboratories, and research institutes each impose distinct specifications, procurement cycles, and quality assurances. As a result, producers must develop adaptable platforms and scalable processes that respond to shifting clinical protocols and regulatory scrutiny.

Moving forward, the sector's near-term priorities include enhancing biocompatibility, ensuring traceability across transfusion chains, and addressing circularity concerns without compromising sterility or patient safety. Strategic collaboration across manufacturers, procurement teams, and clinical governance bodies will be essential to align product evolution with healthcare delivery objectives and sustainability commitments.

Transformative shifts in materials, sterilization technologies, and procurement models that are redefining product lifecycles and clinical workflows

The disposable plastic blood bag landscape is undergoing a series of convergent shifts that extend beyond incremental product improvements. Material innovation is accelerating as manufacturers evaluate non-PVC alternatives to address environmental, regulatory, and safety considerations. These materials must replicate or exceed PVC's performance in flexibility, clarity, chemical compatibility, and cold chain resilience, while also fitting established processing lines. At the same time, sterilization technologies are being reassessed for throughput efficiency, residue profiles, and compatibility with new polymers, prompting reevaluation of supply chain timing and facility certifications.

In parallel, procurement models are transforming. Hospitals and large clinical networks increasingly demand integrated supply agreements, data-driven vendor selection, and lifecycle transparency. This shift is accompanied by a growing emphasis on traceability and batch-level documentation to support hemovigilance and regulatory audits. Moreover, packaging strategies are adapting to component-specific workflows: multi-bag configurations and satellite systems are being optimized for automated fractionation and bedside transfusion. Consequently, manufacturers are prioritizing modular product families that support various collection protocols and component separation needs.

Taken together, these changes are driving a competitive landscape where compliance, adaptability, and sustainability are as crucial as cost and availability. Strategic investments in material R&D, sterilization validation, and supply chain digitization will determine which suppliers can meet evolving clinical requirements while maintaining operational resilience.

Cumulative implications of the United States tariff adjustments in 2025 on sourcing, production location decisions, and procurement resilience

The tariff environment introduced in 2025 has had cascading effects across the disposable plastic blood bag supply chain, altering sourcing priorities and procurement calculus. Tariff adjustments have influenced the relative cost competitiveness of imported raw materials and finished components, prompting manufacturers and purchasing organizations to reassess supplier bases and inventory policies. As a result, firms with diversified sourcing footprints or domestic manufacturing capabilities have experienced improved resilience, while those reliant on single-country suppliers faced elevated logistics and compliance friction.

In response to the tariff measures, several stakeholders accelerated nearshoring and supplier qualification processes to reduce exposure to cross-border duty volatility. This shift has had implications for lead times, capacity planning, and supplier development investments. Additionally, tariff-driven cost pressures intensified conversations around material substitution and design optimization to maintain price competitiveness without compromising clinical performance. Procurement teams have therefore become more engaged in technical evaluation and total cost of ownership discussions, integrating duties, transportation, and quality assurance into supplier scorecards.

Looking forward, the tariff landscape has emphasized the strategic value of flexible supply chains and contractual mechanisms that mitigate duty risk. Collaborative planning between manufacturers and large end users, together with investments in domestic or regional production nodes, will help stabilize availability and manage price exposure. Ultimately, the cumulative impact of the 2025 tariff changes underscores the need for strategic agility and scenario planning across the disposable blood bag ecosystem.

Key segmentation insights revealing how application needs, material choices, sanitization methods, and packaging formats jointly determine clinical suitability

A deep view across application segments shows distinct performance and design imperatives. Based on Application the market is assessed across Plasma, Platelets, Red Blood Cells, and Whole Blood, and within Plasma there are differentiated requirements for Cryoprecipitate, Fresh Frozen Plasma, and Plasma Derivatives that affect bag compatibility with freezing and fractionation processes. Platelets demand specific handling for Apheresis Platelets and Random Donor Platelets, each with implications for anticoagulant volumes, gas permeability, and storage ergonomics. Red Blood Cells collections emphasize options such as Leukoreduced, Standard, and Washed variants where filter and connection design influence processing workflows.

Material choice remains a pivotal driver of manufacturing and clinical performance. Based on Material Type the market is evaluated across non-PVC and PVC substrates, with non-PVC variants increasingly considered for their potential to reduce plasticizer-related concerns and improve recyclability, while PVC continues to offer proven flexibility and cold-chain reliability. End user requirements further refine product specifications. Based on End User the market spans Clinics, Diagnostic Laboratories, Hospitals, and Research Institutes, each imposing distinct procurement cadences, sterility expectations, and regulatory interactions that influence minimum order quantities and packaging preferences.

Packaging type and sterilization methodology also dictate design trade-offs. Based on Packaging Type options include Double Bag, Satellite Bag, and Triple Bag configurations that support various component separation strategies and bedside procedures, while sterilization choices based on Autoclave, Electron Beam, Ethylene Oxide, and Gamma methods impose material compatibility constraints and validation obligations. Capacity considerations based on 250-500 ml, Above 500 ml, and Less Than 250 ml sizes affect manufacturing tooling, storage efficiency, and clinical suitability. Finally, sales channel dynamics based on Direct Sales and Distributors determine who drives product specification decisions and after-sales support, shaping how suppliers allocate commercial resources and technical services.

Region-specific dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape regulatory compliance, distribution, and adoption patterns

Regional dynamics materially influence product adaptation, regulatory compliance, and distribution models. In the Americas market sophistication is often driven by institutional procurement processes, stringent hemovigilance requirements, and a strong emphasis on quality assurance, prompting suppliers to maintain robust documentation and rapid technical support. Regulatory pathways in this region can favor incremental innovation when supported by clinical evidence, and supply networks tend to prioritize reliability and responsiveness for hospital systems and large blood centers.

Across Europe, Middle East & Africa the landscape varies considerably, with certain countries emphasizing sustainability mandates and non-PVC alternatives, while others focus on cost containment and local manufacturing incentives. These differences drive a need for modular product families and flexible sterilization validation packages to meet divergent national regulations and procurement frameworks. In the Asia-Pacific region demand growth is influenced by expanding healthcare infrastructure, rising blood banking capacity, and an increasing adoption of component-based transfusion practices. Consequently, suppliers targeting this region benefit from scalable manufacturing models, regional distribution hubs, and training programs tailored to variable clinical protocols.

Taken together, these regional contrasts necessitate differentiated go-to-market strategies that account for regulatory approvals, sterilization certifications, and logistical realities. Manufacturers and distributors should therefore align product portfolios and service offerings with the dominant procurement logic and clinical priorities of each region to optimize market penetration and long-term relationships.

Key company insights into how capabilities, strategic investments, and validation strengths determine competitive advantage in disposable blood bag supply

Leading companies in the disposable blood bag space are investing in modular product platforms, sterilization compatibility testing, and supplier diversification to maintain operational continuity. Many top-tier manufacturers emphasize quality management systems, regulatory track records, and comprehensive validation documentation to support adoption by large hospitals and blood centers. Competitive differentiation is increasingly achieved through service offerings such as technical training, customized labelling, and extended traceability systems that integrate with hospital information systems.

Capability gaps are apparent among smaller suppliers that may offer competitive pricing but lack validated sterilization pathways or comprehensive post-market surveillance programs. These gaps create opportunities for strategic partnerships, contract manufacturing arrangements, and technology licensing deals. In addition, the shift toward non-PVC materials and multi-bag configurations presents both a challenge and an opportunity: companies that successfully validate novel polymers and demonstrate long-term stability under cryogenic and refrigeration conditions will gain preferential access to quality-sensitive accounts.

Strategic imperatives for market participants include reinforcing regulatory affairs teams, accelerating material science collaborations, and expanding regional manufacturing or distribution footprints to mitigate tariff and logistics risks. Firms that combine technical excellence with flexible commercial models will be best positioned to capture the shifting demand for clinically robust, sustainable, and compliant disposable blood collection systems.

Actionable recommendations for manufacturers and buyers to accelerate material innovation, secure supply chains, and enhance sustainability without compromising clinical performance

Industry leaders should prioritize a balanced strategy that concurrently addresses material innovation, regulatory preparedness, and supply chain resilience. Investing in validated non-PVC prototypes and conducting robust compatibility testing across sterilization methods will reduce exposure to material-specific regulatory or environmental pressures. At the same time, companies should formalize supplier diversification plans and consider regional production nodes to mitigate tariff-induced cost volatility and logistics disruptions. This dual-track approach preserves clinical performance while improving operational flexibility.

Commercially, forging closer partnerships with large hospital systems and blood service organizations will enable co-development of product variants tailored to specific component separation workflows and storage protocols. Enhancing digital traceability and batch-level documentation will support hemovigilance needs and simplify audit processes for procurement teams. In addition, embedding sustainability metrics into product development-such as designing for reduced material usage, recyclability, or take-back programs-can improve brand positioning without compromising sterility or safety.

Finally, organizations should adopt scenario planning and cross-functional governance to rapidly respond to regulatory or tariff changes. Prioritizing investments that simultaneously bolster clinical performance, reduce environmental footprint, and strengthen supply chain redundancy will provide the most durable competitive advantage in a market characterized by evolving clinical expectations and policy dynamics.

Research methodology outlining the multidisciplinary data collection, validation, and cross-verification steps employed to ensure robust and actionable insights

The analysis synthesized primary qualitative inputs from clinical stakeholders, manufacturing experts, and procurement leaders, complemented by secondary literature on materials science, sterilization technologies, and regulatory guidance. Primary inputs were gathered through structured interviews and technical consultations that focused on product specifications, sterilization compatibility, and operational constraints across end users. Secondary sources included peer-reviewed publications, regulatory agency guidance documents, and trade-focused technical papers addressing polymer performance and hemovigilance best practices.

Analytical rigor was maintained through cross-validation of findings across multiple data streams, triangulating clinical requirements with manufacturing feasibility and distribution realities. Validation steps included technical reviews of sterilization compatibility matrices, material stability assessments under cold chain conditions, and consultation with subject matter experts in blood bank operations. Where divergent perspectives emerged, results were reconciled through additional targeted interviews and scenario testing to ensure conclusions reflected practical constraints and stakeholder priorities.

Finally, the research prioritized transparency in assumptions and methodological limitations, documenting validation activities and highlighting areas where further empirical testing or longitudinal surveillance would strengthen confidence. This methodology ensures that insights are grounded in real-world practice while remaining actionable for decision-makers.

Conclusion synthesizing the core strategic imperatives, emergent risks, and opportunity areas for stakeholders in the evolving disposable blood bag market

Conclusion synthesizing strategic imperatives, emergent risks, and priority actions for stakeholders navigating the disposable plastic blood bag landscape

The disposable plastic blood bag sector is at an inflection point where material innovation, sterilization validation, procurement evolution, and geopolitical factors jointly determine competitive outcomes. Stakeholders must reconcile clinical performance and safety with pressures to improve environmental profiles and manage tariff-driven cost exposures. Those organizations that invest in validated non-PVC alternatives, diversify manufacturing and sourcing, and deepen partnerships with clinical end users will be better placed to weather regulatory shifts and supply chain volatility.

Emergent risks include material compatibility challenges under different sterilization regimes, supply disruptions arising from concentrated sourcing, and increasing scrutiny on lifecycle impacts. Conversely, opportunities arise from designing product families that cater to specific component workflows, leveraging traceability and data integration to enhance hemovigilance, and adopting sustainability measures that resonate with procurement criteria. Prioritizing these strategic actions will enable manufacturers and buyers to align clinical efficacy with operational resilience and long-term market relevance.

In summary, a proactive, multidisciplinary approach that integrates material science, regulatory strategy, and supply chain planning will be essential for stakeholders seeking to lead in this evolving landscape. Focused investments and collaborative partnerships will translate insights into tangible improvements across product performance, compliance, and environmental stewardship.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Plastic Blood Bag Market, by Material Type

  • 8.1. Non-Pvc
  • 8.2. Pvc

9. Disposable Plastic Blood Bag Market, by Packaging Type

  • 9.1. Double Bag
  • 9.2. Satellite Bag
  • 9.3. Triple Bag

10. Disposable Plastic Blood Bag Market, by Sterilization Method

  • 10.1. Autoclave
  • 10.2. Electron Beam
  • 10.3. Ethylene Oxide
  • 10.4. Gamma

11. Disposable Plastic Blood Bag Market, by Capacity

  • 11.1. 250-500 Ml
  • 11.2. Above 500 Ml
  • 11.3. Less Than 250 Ml

12. Disposable Plastic Blood Bag Market, by Application

  • 12.1. Plasma
    • 12.1.1. Cryoprecipitate
    • 12.1.2. Fresh Frozen Plasma
    • 12.1.3. Plasma Derivatives
  • 12.2. Platelets
    • 12.2.1. Apheresis Platelets
    • 12.2.2. Random Donor Platelets
  • 12.3. Red Blood Cells
    • 12.3.1. Leukoreduced
    • 12.3.2. Standard
    • 12.3.3. Washed
  • 12.4. Whole Blood

13. Disposable Plastic Blood Bag Market, by End User

  • 13.1. Clinics
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals
  • 13.4. Research Institutes

14. Disposable Plastic Blood Bag Market, by Sales Channel

  • 14.1. Direct Sales
  • 14.2. Distributors

15. Disposable Plastic Blood Bag Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Disposable Plastic Blood Bag Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Disposable Plastic Blood Bag Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Disposable Plastic Blood Bag Market

19. China Disposable Plastic Blood Bag Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvaCare Pharma, Inc.
  • 20.6. B. Braun Melsungen SE
  • 20.7. Baxter International Inc.
  • 20.8. Beijing Bode Sangte Blood Equipment Technology Development Center
  • 20.9. Fresenius Kabi AG
  • 20.10. GenesisBPS
  • 20.11. Grifols, S.A.
  • 20.12. Haemonetics Corporation
  • 20.13. HLL Lifecare Limited
  • 20.14. Innvol Medical India Ltd.
  • 20.15. JMS Co., Ltd.
  • 20.16. Macopharma S.A.
  • 20.17. Ningbo David Medical Device Co., Ltd.
  • 20.18. Nipro Corporation
  • 20.19. Poly Medicure Limited
  • 20.20. SB-Kawasumi Laboratories Inc.
  • 20.21. Shandong Yimei Medical Technology Co., Ltd.
  • 20.22. Shanghai Transfusion Technology Co., Ltd.
  • 20.23. Sichuan Mianzhu Hongji Pharmaceutical Co., Ltd.
  • 20.24. SURU International Pvt. Ltd.
  • 20.25. Terumo Corporation
  • 20.26. Wego Holding Co., Ltd.
  • 20.27. Zhengzhou Feilong Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DOUBLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SATELLITE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY TRIPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY AUTOCLAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LESS THAN 250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APHERESIS PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RANDOM DONOR PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY LEUKOREDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WASHED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 207. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 240. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 243. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 247. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 251. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 254. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLASMA, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY PLATELETS, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY RED BLOOD CELLS, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA DISPOSABLE PLASTIC BLOOD BAG MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)